These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17890746)

  • 41. Do more diabetic patients need insulin?
    Page S; Tattersall R
    Practitioner; 1996 Feb; 240(1559):104-8. PubMed ID: 8736198
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secondary sternal Aspergillus osteomyelitis in a diabetic hemodialysis patient with previous allograft rejection.
    Natesan S; Abraham G; Mathew M; Lalitha MK; Srinivasan CN
    Hemodial Int; 2007 Oct; 11(4):403-5. PubMed ID: 17922735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward achieving euglycemia in kidney transplanted and hemodialysis diabetics.
    Levitz CS; Hirsch S; Ross JM; Butt KM; Friedman EA
    Proc Clin Dial Transplant Forum; 1980; 10():248-52. PubMed ID: 7050985
    [No Abstract]   [Full Text] [Related]  

  • 46. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study.
    Liebl A; Breitscheidel L; Nicolay C; Happich M
    Curr Med Res Opin; 2008 Aug; 24(8):2349-58. PubMed ID: 18606055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Achieve better glucose control for your hospitalized patients.
    Woolever DR
    J Fam Pract; 2008 Dec; 57(12):782-8. PubMed ID: 19080760
    [No Abstract]   [Full Text] [Related]  

  • 48. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y; Guo XH; Vaz JA;
    Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors associated with symptomatic hypoglycemia in type 2 diabetes mellitus patients.
    Durán-Nah JJ; Rodríguez-Morales A; Smitheram J; Correa-Medina C
    Rev Invest Clin; 2008; 60(6):451-8. PubMed ID: 19378831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study.
    Bringer J; Fontaine P; Detournay B; Nachit-Ouinekh F; Brami G; Eschwege E
    Diabetes Metab; 2009 Feb; 35(1):25-31. PubMed ID: 19046913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determining effective insulin analog therapy based on the individualized needs of patients with type 2 diabetes mellitus.
    Gong WC
    Pharmacotherapy; 2008 Oct; 28(10):1299-308. PubMed ID: 18823224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 48-year-old man with uncontrolled diabetes.
    Hu M; Isaacson JH
    Cleve Clin J Med; 2009 Jul; 76(7):413-6. PubMed ID: 19570974
    [No Abstract]   [Full Text] [Related]  

  • 55. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 56. Insulin resistance, kidney damage, and gender.
    Kordella T
    Diabetes Forecast; 2005 Sep; 58(9):40. PubMed ID: 16187434
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of decompensated diabetic nephropathies through hemodialyses. 1. Review of treatment results for the first 2 years.
    Langsch HG; Bombor H
    Dtsch Gesundheitsw; 1972 Dec; 27(50):2371-5. PubMed ID: 4651199
    [No Abstract]   [Full Text] [Related]  

  • 58. Kidney damage in diabetes.
    Carroll R
    Nursing (Lond); 1992 Mar 26-Apr 8; 5(6):17-20. PubMed ID: 1579283
    [No Abstract]   [Full Text] [Related]  

  • 59. [Dialysis therapy in elderly patients--selected aspects. Can patients treated by hemodialysis cease further therapy?].
    Kopeć J; Sułowicz W
    Przegl Lek; 2014; 71(7):374-7. PubMed ID: 25338332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients.
    Ruggian JC; Maesaka JK; Fishbane S
    Am J Kidney Dis; 1996 Sep; 28(3):409-14. PubMed ID: 8804240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.